Recurrent Exon-Deleting Activating Mutations in AHR Act as Drivers of Urinary Tract Cancer

Read it now on PracticeUpdate.com

Read the full article here

Source: PracticeUpdate
Categories: Hem/Oncs, Latest Headlines
Tags: , ,
Tweets with this article
Guru Sonpavde, MD
Recurrent Exon-Deleting Activating Mutations in AHR Act as Drivers of #UrinaryTract #Cancer #bladdercancer-inducing ligand-independent AHR-pathway activation-relevant in ~10% of patients @ecuppen @ewartkuijk @HartwigMedical @FaltasLab https://t.co/goIFtlQk3D @practiceupdate

Related Articles